Be Aware of SGLT2 Inhibitor Risks

May 2020

SGLT2 inhibitor (Jardiance, etc) risks will be back in the spotlight...due to recent label changes.

These meds are getting more use now that most have proven CV benefits...despite usually costing about $500/month.

Be familiar with how to manage SGLT2 inhibitor risks.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote